1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Θετικών Επιστημών
  4. Τμήμα Χημείας
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/9617
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNakou, E. S.en
dc.contributor.authorFilippatos, T. D.en
dc.contributor.authorKiortsis, D. N.en
dc.contributor.authorDerdemezis, C. S.en
dc.contributor.authorTselepis, A. D.en
dc.contributor.authorMikhailidis, D. P.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T16:50:32Z-
dc.date.available2015-11-24T16:50:32Z-
dc.identifier.issn1465-6566-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/9617-
dc.rightsDefault Licence-
dc.subjectcholesterolen
dc.subjectezetimibeen
dc.subjecthigh-density lipoproteinen
dc.subjectlipoprotein associated phospholipase a(2)en
dc.subjectorlistaten
dc.subjectparaoxonaseen
dc.subjectsubclassesen
dc.subjecttriglyceridesen
dc.subjectactivating-factor-acetylhydrolaseen
dc.subjectcardiovascular risk-factorsen
dc.subjectcoronary-heart-diseaseen
dc.subjectintervention trialen
dc.subjectphospholipase a(2)en
dc.subjectmetabolic syndromeen
dc.subjectcholesterolen
dc.subjectsubfractionsen
dc.subjectparaoxonaseen
dc.subjectldlen
dc.titleThe effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemiaen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDoi 10.1517/14656560802548430-
heal.identifier.secondary<Go to ISI>://000262018400003-
heal.identifier.secondaryhttp://informahealthcare.com/doi/abs/10.1517/14656560802548430-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2008-
heal.abstractBackground: High-density lipoprotein (HDL) includes discrete subfractions. HDL exhibits anti-atherogenic properties, which have been partly linked to the activity of HDL-associated enzymes, such as the lipoprotein associated phospholipase A(2) (HDL-LpPLA(2)) and paraoxonase-1 (PON1). Objective: We assessed in an open-label randomised study the effect of orlistat and ezetimibe, alone or in combination, on plasma HDL subclasses and HDL-associated enzyme activities in overweight and obese subjects (body mass index > 28 kgm(2)) with hypercholesterolemia [total cholesterol > 200 mg/100 ml (5.2 mmol/l)]. Methods: Eighty-six people were prescribed a low-fat low-calorie diet and were randomly allocated to receive orlistat 120 mg, three times daily (O group), ezetimibe 10 mg/day (E group) or both (OE group) for 6 months. HDL subfractions were determined using a polyacrylamide gel-tube electrophoresis method. Results: Levels of HDL cholesterol (HDL-C) and apolipoprotein Al did not change significantly in any group. In group O the cholesterol concentration of HDL-2 subclass increased significantly, while the cholesterol of HDL-3 subclass decreased significantly. In groups E and OE HDL-2 subclass did not significantly change, while the cholesterol concentration of HDL-3 subclass decreased significantly. We observed a non-significant decrease in the HDL-LpPLA(2) and POW activity in all groups. However, the ratios of both enzyme activities to low-density lipoprotein cholesterol (LDL-C) levels (an index of atherogenicity) significantly increased in all groups. Conclusion: Although HDL-C levels did not change after treatment with orlistat and ezetimibe, alone or in combination, there were alterations of the HDL-2 and HDL-3 subclasses. The activity of HDL-LpPLA(2) and POW per mg LDL-C increased significantly in all groups.en
heal.journalNameExpert Opinion on Pharmacotherapyen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Show simple item record
Files in This Item:
There are no files associated with this item.
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons